CompletedPhase 4ketamine

Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy

Sponsored by Complexo Hospitalario Universitario de A Coruña

NCT ID
NCT02909049
Target Enrollment
100 participants
Start Date
2016-04
Est. Completion
2018-01-24

About This Study

To assess the effectiveness of two anesthetic techniques by measuring the pain through visual analog scale (VAS), to obtain saturation prostate biopsies.

Conditions Studied

Prostatic Cancer

Interventions

  • MIDAZOLAM
  • MEPIVACAÍNE
  • FENTANILE
  • KETAMINE

Eligibility

Sex:MALE
Age:18 Years - 75 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Male patient
* Persistence of suspected prostate cancer by altering the prostatic specific antigen and / or digital rectal examination.
* Two previous negative prostate biopsies .
* Age \< 75 years.
* Signature of informed consent to perform prostate biopsy.
* Signature of informed consent for the study.

Exclusion Criteria:

* Age \> 75 years.
* Absence of consent or refusal to the study .
* Presence of prostate cancer in previous biopsy observation .
* Medical-surgical patient's problems, absolutely contraindicating biopsy under local anesthesia.
* Presence of any allergies to medications involved in the study .
* Patient's clinical situation that does not allow an outpatient operation and aftercare required .
* Medical condition of the patient, preventing the realization of outpatient biopsy.
* No companion.

Study Locations (1)

Jose Luis Ponce Diaz-Reixa
A Coruña, Spain

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source